Statins impair glucose uptake in tumor cells

Area of Science:

• Biochemistry
• Oncology
• Medical Imaging

Background:

• Statins are crucial for managing hypercholesterolemia and offer cardiovascular protection.
• Emerging evidence suggests statins may have therapeutic applications in oncology.
• Cancer cells exhibit altered glucose metabolism, often relying on increased glucose uptake.

Purpose of the Study:

• To investigate the effect of statins on glucose uptake in cancer cells.
• To explore the underlying mechanisms of statin-mediated inhibition of glucose uptake.
• To assess the impact of statins on diagnostic imaging modalities that rely on glucose metabolism.

Main Methods:

• Utilized various statins and glucose analogs (e.g., (18)FDG, 6-NBDG) to measure glucose uptake in multiple cancer cell lines.
• Investigated the role of cholesterol synthesis inhibition in blocking glucose uptake.
• Conducted an exploratory clinical study involving patients treated for hypercholesterolemia undergoing PET-CT imaging.

Main Results:

• Statins demonstrated significant inhibition of glucose uptake across several cancer cell lines.
• The blockade of glucose uptake was directly linked to the inhibition of cholesterol synthesis.
• Exploratory clinical data indicated potential alterations in PET-CT imaging findings in a patient receiving statins.

Conclusions:

• Statins inhibit cancer cell glucose uptake, likely by interfering with cholesterol synthesis.
• These findings suggest a potential impact of statin therapy on cancer cell metabolism and diagnostic imaging.
• Further large-scale clinical studies are warranted to validate these observations and elucidate molecular mechanisms.